Vivos Therapeutics, Inc.VVOSNASDAQ
Loading
Enterprise value to EBITDA ratio
Latest
-1.59
↑ 70% vs avg
Percentile
P50
Within normal range
Streak
2 yr
Consecutive declineContracting
Average
-5.32
Historical baseline
| Period | Value | YoY Change |
|---|---|---|
| 2024 | -1.59 | -70.9% |
| 2023 | -0.93 | -178.4% |
| 2022 | -0.33 | +74.3% |
| 2021 | -1.30 | +83.9% |
| 2020 | -8.07 | +30.7% |
| 2019 | -11.64 | +12.9% |
| 2018 | -13.36 | - |